Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Inje Educational Foundation

Home Clinical Trial Sponsors and OrganizationsInje Educational Foundation

Inje Educational Foundation

75 Bokji-ro, Busanjin-gu, Busan, South Korea

Also known as:

inje university busan paik hospital

inje university ilsan paik hospital

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

32

7 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

29

90.6%

Unknown

2

6.3%

Trial Status Distribution

Active, not recruiting

1

3.1%

Completed

13

40.6%

Not yet recruiting

6

18.8%

Recruiting

11

34.4%

Withdrawn

1

3.1%

Clinical Trials

Trials sponsored by this organization (32)

Prognostic significance of HER2 expression in patients with resectable gastric cancer

Sep 2018782 participants

Comparison of the efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin for target low-density lipoprotein goal achievement in patients with recent ischemic stroke

584 participants

A dose block-randomized, double-blind, placebo-controlled, single/multiple dosing, dose-escalation clinical phase 1 trial to investigate the safety, tolerability, and pharmacokinetics of DWP09031 after oral administration in healthy male subjects

64 participants

Development for an immortalized standard cell lines of disease genetics

Not yet recruiting

250 participants

Evaluation of performance of phase-lag entropy

160 participants

Randomized, open-label, crossover study to evaluaute an effects of genetic polymorphism on pharmacokinetic & pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers

27 participants

Efficacy and safety of basal insulin/metformin/lobeglitazone or basal insulin/metformin/linagliptin in patients with Type 2 diabetes mellitus inadequately controlled by basal insulin plus metformin with or without another oral hypoglycemic agent : an open-label, randomised phase 4 study.

82 participants

A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanil

Not yet recruiting

15 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials32
Approvals
News

Back to Organizations